1963
DOI: 10.1016/s0065-230x(08)60983-5
|View full text |Cite
|
Sign up to set email alerts
|

Mechanisms of Resistance to Anticancer Agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
31
0

Year Published

1964
1964
2013
2013

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 143 publications
(33 citation statements)
references
References 451 publications
2
31
0
Order By: Relevance
“…Iron chelators by affecting intracellular and extracellular iron transport and storage may inhibit DNA synthesis and other metabolic processes dependent on iron [2,4,5]. A direct effect on the iron-dependent enzyme ribonucleotide reductase has been shown in a cell free system [6], and has been postulated in the intact cell [7,8]. Effective iron chelators like desferrioxamine may inhibit the toxicity of iron in vitro, but less effective ones like EDTA may exacerbate its toxic effects [9,10] Desferrioxamine has been reported to inhibit DNA synthesis in a variety of cell culture systems, although the effect has only been seen at high drug concentrations or with prolonged exposure of the cells to the drug [ 1 l-131.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Iron chelators by affecting intracellular and extracellular iron transport and storage may inhibit DNA synthesis and other metabolic processes dependent on iron [2,4,5]. A direct effect on the iron-dependent enzyme ribonucleotide reductase has been shown in a cell free system [6], and has been postulated in the intact cell [7,8]. Effective iron chelators like desferrioxamine may inhibit the toxicity of iron in vitro, but less effective ones like EDTA may exacerbate its toxic effects [9,10] Desferrioxamine has been reported to inhibit DNA synthesis in a variety of cell culture systems, although the effect has only been seen at high drug concentrations or with prolonged exposure of the cells to the drug [ 1 l-131.…”
Section: Introductionmentioning
confidence: 99%
“…Effective iron chelators like desferrioxamine may inhibit the toxicity of iron in vitro, but less effective ones like EDTA may exacerbate its toxic effects [9,10] Desferrioxamine has been reported to inhibit DNA synthesis in a variety of cell culture systems, although the effect has only been seen at high drug concentrations or with prolonged exposure of the cells to the drug [ 1 l-131. Other potential iron chelating drugs may be more effective in inhibiting DNA synthesis [7,11], and some have been reported to be cytotoxic [ 11,14,15]. …”
Section: Introductionmentioning
confidence: 99%
“…First, since it has been reported that cAMP and the 3', 5'-cyclic phosphate of 9-fl-D-arabinofuranosyladenine may cross cell membranes (9,13,14), the possibility of other cyclic nucleotides having this property appears to be reasonable. Hence, assuming the compounds are acting at the 5'-mono-, di-, or triphosphate level in the cell, as do other purine and pyrimidine nucleosides (1,2,5,7,21), little additional alteration of the molecule would be required by the host system. Meyer et al (10) have shown that hydrolysis of these compounds by the ubiquitous cyclic nucleotide phosphodiesterase is necessary to produce the 5'-monophosphate.…”
Section: Resultsmentioning
confidence: 99%
“…On a biochemical level, this inhibition of mitosis has been mediated through a nucleic acid mechanism. Thus in the case of the alkylating agents (32), the antipurines (33), and the folic acid antagonists (34), inhibition of DNA synthesis appears to be responsible for the inhibition of mitosis, although an RNA mechanism has not been ruled out. The mechanism of action of actinomycin D is probably through DNA-dependent RNA synthesis (35).…”
Section: Immune Suppression By Vincristine and Vinblastinementioning
confidence: 99%